DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $17.06 million. The enterprise value is $26.73 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, before market open.
Earnings Date | Nov 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 2.40 million shares outstanding. The number of shares has increased by 63.26% in one year.
Current Share Class | 2.40M |
Shares Outstanding | 2.40M |
Shares Change (YoY) | +63.26% |
Shares Change (QoQ) | +4.77% |
Owned by Insiders (%) | 11.83% |
Owned by Institutions (%) | 19.16% |
Float | 2.10M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.71 |
Forward PS | 0.53 |
PB Ratio | 0.25 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.98 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.30, with a Debt / Equity ratio of 0.49.
Current Ratio | 3.30 |
Quick Ratio | 2.77 |
Debt / Equity | 0.49 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -66.92% and return on invested capital (ROIC) is -26.75%.
Return on Equity (ROE) | -66.92% |
Return on Assets (ROA) | -22.55% |
Return on Invested Capital (ROIC) | -26.75% |
Return on Capital Employed (ROCE) | -42.18% |
Revenue Per Employee | $134,396 |
Profits Per Employee | -$176,811 |
Employee Count | 202 |
Asset Turnover | 0.24 |
Inventory Turnover | 1.70 |
Taxes
In the past 12 months, DarioHealth has paid $164,000 in taxes.
Income Tax | 164,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -55.00% in the last 52 weeks. The beta is 1.11, so DarioHealth's price volatility has been higher than the market average.
Beta (5Y) | 1.11 |
52-Week Price Change | -55.00% |
50-Day Moving Average | 11.17 |
200-Day Moving Average | 13.39 |
Relative Strength Index (RSI) | 31.32 |
Average Volume (20 Days) | 33,101 |
Short Selling Information
The latest short interest is 162,810, so 6.78% of the outstanding shares have been sold short.
Short Interest | 162,810 |
Short Previous Month | 3.13M |
Short % of Shares Out | 6.78% |
Short % of Float | 7.74% |
Short Ratio (days to cover) | 11.32 |
Income Statement
In the last 12 months, DarioHealth had revenue of $27.15 million and -$35.72 million in losses. Loss per share was -$13.13.
Revenue | 27.15M |
Gross Profit | 18.87M |
Operating Income | -41.58M |
Pretax Income | -52.73M |
Net Income | -35.72M |
EBITDA | -35.26M |
EBIT | -41.58M |
Loss Per Share | -$13.13 |
Full Income Statement Balance Sheet
The company has $21.95 million in cash and $31.62 million in debt, giving a net cash position of -$9.67 million or -$4.03 per share.
Cash & Cash Equivalents | 21.95M |
Total Debt | 31.62M |
Net Cash | -9.67M |
Net Cash Per Share | -$4.03 |
Equity (Book Value) | 63.99M |
Book Value Per Share | 28.14 |
Working Capital | 22.42M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$26.79 million and capital expenditures -$128,000, giving a free cash flow of -$26.92 million.
Operating Cash Flow | -26.79M |
Capital Expenditures | -128,000 |
Free Cash Flow | -26.92M |
FCF Per Share | -$11.22 |
Full Cash Flow Statement Margins
Gross margin is 69.49%, with operating and profit margins of -153.15% and -162.73%.
Gross Margin | 69.49% |
Operating Margin | -153.15% |
Pretax Margin | -162.13% |
Profit Margin | -162.73% |
EBITDA Margin | -129.87% |
EBIT Margin | -153.15% |
FCF Margin | n/a |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -63.26% |
Shareholder Yield | -63.26% |
Earnings Yield | -209.32% |
FCF Yield | -157.78% |
Analyst Forecast
The average price target for DarioHealth is $50.00, which is 603.24% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $50.00 |
Price Target Difference | 603.24% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 18.34% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 28, 2025. It was a reverse split with a ratio of 1:20.
Last Split Date | Aug 28, 2025 |
Split Type | Reverse |
Split Ratio | 1:20 |
Scores
DarioHealth has an Altman Z-Score of -5.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.84 |
Piotroski F-Score | 4 |